Accrued liabilities consisted of the following (in thousands):
March 31,
2023
December 31,
2022
Accrued liabilities:
General and administrative
$
1,066
855
Clinical trial related costs
2,023
1,327
Non-clinical research and manufacturing operations
1,182
1,779
Payroll related
1,243
4,828
Other accrued expenses
28
34
Total Accrued liabilities
5,542
8,823
No definition available.
Tabular disclosure of the components of accrued liabilities.